HHS redirects $500 million to Trump appointee's vaccine project, bypassing reviews
The Department of Health and Human Services has transferred $500 million from research into next-generation COVID-19 vaccines, redirecting the money to a single vaccine project linked to the Trump administration's former acting head of the National Institutes of Health.
Multiple federal health officials said they were surprised by the announcement, which bypassed the usual procedures overseen by career scientists at the NIH and the Biomedical Advanced Research and Development Authority, known as BARDA. Those reviews are intended to ensure that federal research money goes to the projects with the greatest scientific merit.
The HHS says the initiative, dubbed "Generation Gold Standard," aims to start clinical trials next year for universal influenza vaccines that could protect against any strain of the virus. It hopes to get a vaccine approved by the Food and Drug Administration by 2029.
All of the money is being transferred to an influenza vaccine project called beta-propiolactone or BPL, according to emails seen by CBS News. Two officials said the decision to pour $500 million into a single vaccine platform is unusual, given the limited data on it.
The transfer makes it effectively one of the largest awards to date from a BARDA effort to speed funding to new experimental vaccines and treatments, topping a previous award of $452 million to a company developing an experimental oral COVID-19 vaccine.
An HHS spokesperson told CBS News that "decision-making for project Generation Gold Standard was a collaborative process, between leaders of HHS, in an effort to direct funding for a BPL vaccine for all influenza threats, not just one."
The Wall Street Journal previously reported news of the project.
The vaccine underwent testing for safety results earlier this year in a small study led by NIH researchers Dr. Matthew Memoli and Dr. Jeffery Taubenberger. The research was what scientists call a Phase 1 study, the first step to researching a potential vaccine in humans.
Memoli had served as the acting head of the NIH during a controversial transition in recent months, overseeing Trump administration directives like steep cuts to research funding and the medical research agency's staff and leadership.
Taubenberger, who holds a patent for the BPL vaccine platform, was picked to be the acting head of the National Institute of Allergy and Infectious Diseases, or NIAID, after the institute's previous director was ousted.
BARDA and NIH officials were ordered to redirect the money to Memoli's research by Noah Miller, a special assistant hired by Health and Human Services Secretary Robert F. Kennedy Jr., according to emails seen by CBS News. Two officials said it was unusual for a political appointee to handpick a project or researcher to be funded without vetting from career scientists or outside review.
The money is coming from the "Project NextGen" initiative, a $5 billion effort launched under the Biden administration that had previously funded multiple research projects into studying potential COVID-19 vaccines and treatments.
The NIH had previously awarded $62.4 million in grant money to researchers at seven universities working on "pan-coronavirus" vaccines.
From BARDA, the department had also backed four vaccine makers going into larger Phase 2B clinical trials to study experimental COVID-19 vaccines, in awards totaling $551 million.
Those followed requests by the NIH and BARDA for researchers and vaccine companies to submit proposals for backing from the federal government.
Another HHS spokesperson, Vianca Rodriguez Feliciano, said in an email that the department's new initiative "realigns BARDA with its core mission: preparing for all flu viral pathogens, not just COVID-19."
"It delivers a cost-effective, accountable alternative to the Biden administration's wasteful Project NextGen, which spent $1.63 billion on COVID-19 vaccines and $1.19 billion on therapeutics, neglecting broader pandemic preparedness," Feliciano said.
In its release, the department described the decision as a "decisive shift toward transparency, effectiveness, and comprehensive preparedness," by focusing on "in-house development" of vaccines instead of projects from outside researchers.
It is also planning to develop other vaccines for COVID-19 using BPL, which it calls "traditional vaccine technology brought into the 21st century."
"Our commitment is clear: every innovation in vaccine development must be grounded in gold standard science and transparency, and subjected to the highest standards of safety and efficacy testing," Kennedy said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Trump stokes fear, confusion with pulled emergency abortion guidance
The Trump administration sowed confusion and fear among physicians with its move this past week to rescind Biden-era guidelines to hospitals that provide life-saving abortions. While the move doesn't change the law, doctors and reproductive-rights advocates fear it will have a chilling effect on health care workers in states with abortion bans, ultimately harming pregnant women. Earlier this past week, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced they would rescind guidance issued during the Biden administration, which reinforced to hospitals that under the Emergency Medical Treatment and Labor Act (EMTALA,) abortions qualify as stabilizing care in medical emergencies. Emergency rooms in states with abortion bans have been struggling since the 2022 overturning of Roe v. Wade to understand when they can legally provide emergency abortions. After President Trump pulled the Biden-era guidance seeking to clarify that question, emergency room doctors will experience 'more confusion' and 'more fear,' according to health and legal experts who spoke with The Hill. 'Clinicians are scared to provide basic medical care, and this care is clearly in line with medical ethics … medical standards of care, and they're being put in this situation where they can't win,' said Payal Shah, director of research, legal and advocacy at Physicians for Human Rights. Since the Supreme Court overturned Roe v. Wade in 2022, at least 13 states have enacted near-total abortion bans, according to data from the Guttmacher Institute. There are exceptions in these states when continuing a pregnancy poses a threat to the health or life of the mother. However, most of the language in state laws is unclear on how that determination is made, resulting in instances of emergency rooms denying care. Doctors in states like Idaho, Texas and Tennessee have filed lawsuits requesting that lawmakers clarify when an abortion is allowed to save the life of a pregnant person. The doctors and patients involved in the lawsuits argue that state laws do not adequately protect pregnant patients in emergencies. Many of these states have severe punishments for doctors who violate abortion bans, like steep fines and prison time. 'For clinicians, there is actually no safe way to navigate this in this moment, and ultimately, that's how these laws are designed,' Shah said. 'They're designed to cause chaos and confusion. They're often written in ways that don't use medical terminology.' Without clear guidance, pregnant women suffer and sometimes die, as ProPublica has reported. One striking example of this is the 2023 case of Kyleigh Thurman, a Texas woman who was repeatedly denied care for a nonviable pregnancy after days of experiencing bleeding and pain. Health care workers discovered that she had an ectopic pregnancy, which is when a fertilized egg implants and begins to grow outside of the uterus, usually in a fallopian tube. Ectopic pregnancies are never viable and are life-threatening if not treated properly. It wasn't until her OB/GYN 'pleaded to hospital staff that she be given care,' that the hospital administered a shot ending her pregnancy, according to a complaint filed by the Center for Reproductive Rights on behalf of Thurman. The shot came too late, and the ectopic pregnancy ruptured Thurman's right fallopian tube, which was then removed. 'If a patient is actively hemorrhaging or experiencing an ectopic pregnancy which is also life-threatening, doctors need that clear guidance that yes, EMTALA applied,' said Autumn Katz, associate director of U.S. litigation at the Center for Reproductive Rights. A federal investigation into Thurman's case found that the Texas hospital violated EMTALA, according to a recent letter from the CMS. 'I finally got some justice,' Thurman said in a statement. 'I hope this decision will do some good in encouraging hospitals to help women in situations like mine.' Hospitals that violate EMTALA are subject to heavy fines and, in some extreme cases, risk losing a portion of their Medicare and Medicaid hospital funding, according to the National Institutes of Health. Former President Biden leaned on the law to preserve access to emergency abortion across the country, leading to a legal fight with Idaho, which has a strict abortion ban. The Supreme Court last year dismissed the case, declining to rule on the merits of a politically charged case. The rescinding of these guidelines also means hospitals that violate the law will likely not be investigated as often as they were under previous administrations, according to Shah. That lack of punitive risk means that hospitals could be incentivized to deny life-saving care for patients. 'The standard of EMTALA is pretty high,' said Katherine Hempstead, senior policy adviser at Robert Wood Johnson Foundation. 'This kind of takes that layer of reassurance away, and it will make a lot of providers feel very vulnerable.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
31 minutes ago
- Yahoo
NASA, Pentagon push for SpaceX alternatives amid Trump's feud with Musk
NASA and Pentagon officials moved swiftly this past week to urge competitors to Elon Musk's SpaceX to more quickly develop alternative rockets and spacecraft after President Donald Trump threatened to cancel Space X's contracts and Musk's defiant response. Government officials were especially stunned after Musk responded to Trump with a salvo of his own: SpaceX would stop flying its Dragon spacecraft, a move that would leave the space agency with no way to transport its astronauts to the International Space Station. Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Musk later recanted his threat. But it alarmed officials at NASA, which entrusts SpaceX with the lives of its astronauts, and at the Pentagon, which relies heavily on the company to launch its most sensitive satellites. The worried reaction within space and national security agencies highlights the risks of the government's heavy dependence on SpaceX for crucial tasks, including classified missions. SpaceX, with billions of dollars in government contracts, flies people and cargo to the ISS, launches satellites for the Pentagon and develops satellites used by intelligence agencies. The concerns are compounded by the fact that its competitors have been slow to catch up, leaving SpaceX's dominance largely unchallenged and the government with few options. This account is based on interviews with a dozen people in industry and government who spoke on the condition of anonymity because they were not authorized to speak publicly about internal deliberations. One NASA official said that watching the feud between Trump and Musk play out on social media Thursday at first was 'entertaining.' But once Musk called for decommissioning Dragon, 'it turned really terrifying.' There was a similar reaction in the Pentagon, where a person said staff officers 'looked at each other and said, 'oh, it's not funny anymore.' There was a realization that we're not watching TV. This is a real issue.' Musk's behavior has worried NASA officials before. In 2018, NASA ordered an investigation into SpaceX's safety culture after Musk appeared to take a small hit of marijuana on the Joe Rogan podcast. But his sudden threat on social media to cut off NASA's access to the orbiting space station, which has cost NASA some $100 billion over its lifespan, 'crossed a line,' one former space agency official said. 'When you realize that he's willing to shut everything down just on an impulse, that kind of behavior and the dependence on him is dangerous. … I can tell you there is deep concern within NASA.' The rift between Musk and Trump was also fueled by the White House's withdrawal of Jared Isaacman's nomination to be NASA administrator. Isaacman had flown to space twice with SpaceX and was seen as closely aligned with Musk. SpaceX did not respond to a request for comment. Since Thursday's exchange, at least three commercial space companies, RocketLab, Stoke Space and Jeff Bezos's Blue Origin, have been contacted by government officials about the status of their rockets and when they might be available for government missions, according to four people familiar with the inquiries. (Bezos owns The Washington Post.) Officials at Sierra Space, which is developing a Dream Chaser spaceplane that could deliver cargo to the space station, were in a meeting with NASA officials on Thursday as the Trump-Musk feud was getting underway. 'Sierra Space stands ready to ensure uninterrupted support for the International Space Station,' Fatih Ozmen, the company's CEO, said in a statement to The Post. He added that 'NASA mentioned to us that they want diversity and do not want to rely on a single provider.' Dream Chaser 'is in final testing and integration at Kennedy Space Center,' Ozmen said. 'We are working closely with NASA leadership to fly the vehicle later this year.' The company is also working on a variant of Dream Chaser to carry astronauts, he said, 'which NASA is studying.' Musk's declaration also rattled staffers on Capitol Hill. A key congressional committee asked about the status of Boeing's Starliner space capsule vehicle, according to a person with knowledge of the inquiry. NASA intends to use Starliner to fly crews to the space station along with SpaceX's Dragon capsule. The spacecraft is years behind schedule, however, and during its first human spaceflight mission to the ISS last summer, it ran into so many problems that NASA decided it was unsafe to return to the crew with Boeing. But with Musk threatening to end Dragon, the congressional aide wanted to know when Starliner would be ready to fly again. In recent months, NASA has said little about the status of Starliner. But in response to reporters' questions, the agency issued a statement late Friday saying that it is planning for a Starliner flight to the space station 'in early 2026, pending system certification and resolution of Starliner's technical issues.' NASA is still evaluating whether the capsule would fly with astronauts on board or with cargo only. Even though he later recanted, Musk's threat to curtail NASA's use of Dragon could be damaging to a company that has been one of the government's most trusted partners, said Todd Harrison, a defense analyst at the American Enterprise Institute. 'It's almost like an embargo of the space station,' he said. 'Musk was saying he is going to cut NASA off from its own laboratory in space.' Harrison said the threat was reminiscent of Musk's refusal to activate the Starlink Internet system so that Ukraine could carry out an attack on Russian forces in 2022. That decision also prompted an outcry that the nation's defenses should not be in the hands of a single person or company. Given that SpaceX has experience operating its Starlink Internet satellite constellation, it had been considered to be a natural choice for Trump's proposed Golden Dome missile defense shield, which would rely on swarms of satellites in orbit. But Musk's threat was so impulsive that it will undoubtedly rattle defense officials, Harrison said, who would not look favorably on the 'idea that the nation's missile defenses could be held hostage to the twittering whims of Elon Musk.' For NASA's astronauts, Musk's social media post 'got very personal' because it could impact their ability to fly, said Garrett Reisman, a former NASA astronaut who previously worked at SpaceX. 'We shouldn't overreact to a fit of pique on social media. But when your hopes and dreams are tied up in this, you can't help but think, 'Oh my goodness am I going to fly in space?'' The Pentagon has recently made an effort to broaden the military and space industrial base, allowing for competition to drive down cost and increase innovation. The Space Force last year released a strategy that said the service would seek to avoid 'overreliance on any single provider or solution.' To allow more companies to vie for lucrative space contracts, the Pentagon recently created two 'lanes' of launch competitions. Lane 1 allows new entrants to bid on individual contracts to launch satellites that are smaller and not as vital; Lane 2 would be reserved for more powerful and proven rockets that would hoist satellites that cannot risk failure. SpaceX, however, has continued to dominate those missions. Its Falcon 9 rocket launches at an unprecedented cadence, while those of its competitors, including the United Launch Alliance's Vulcan, Blue Origin's New Glenn and RocketLab's Neutron, are still largely unproven. New Glenn has launched just once; Vulcan twice; Neutron not at all. And even before Musk's social media posting, the Pentagon publicly expressed worry about the pace of Vulcan's development even though it has won certification to fly national security missions. In a statement to the House Armed Services Committee last month, U.S. Space Force Maj. Gen. Stephen Purdy said that contractors like ULA must 'establish a culture of accountability, and repair trust deficit to prove to the [Service Acquisition Executive for Space] that they are adopting the acquisition principles necessary to deliver capabilities at speed, on cost and on schedule.' From a legal and practical standpoint, the threats by the president and Musk would be difficult to carry out, said procurement specialists. If either the government or the company opted out, they would face major financial penalties, government procurement experts said. And if the contractor pulled out, it could affect its ability to win future contracts. Still, some had warned about Musk's foray into politics and the consequences for his companies. In an interview last year, Peter Beck, the CEO of RocketLab, which is seeking to compete for national security launch contracts, predicted that Musk's acquisition of Twitter, now X, and time at Trump's side could end up hurting his businesses. 'It certainly makes people uncomfortable,' he said at the time. 'At the end of the day, if you're delivering important national security missions, the buck stops with the CEO.' Related Content To save rhinos, conservationists are removing their horns Donald Trump and the art of the Oval Office confrontation Some advice from LGBTQ elders as WorldPride kicks off amid fears
Yahoo
2 hours ago
- Yahoo
Measles resurgence highlights the toll of RFK Jr.'s anti-vaccine policies
After the U.S. surpassed 1,000 reported measles cases nationwide, it's clear the Trump administration is failing to protect our health and well-being. The measles outbreak in Texas is now the largest since 2000, when the country eliminated measles. And it's not yet over, threatening to make measles endemic in America again, where the risk of infection comes from within our country. Furthermore, two unvaccinated school-aged children in Texas died from measles, the first American children to die from the viral infection since 2003. Normally, a preventable infection causing avoidable deaths of children would lead to prompt government action. In 1991, I was a medical student with the U.S. Public Health Service in Philadelphia during a large measles outbreak. Over 1,000 people were infected, and nine children died. Government and public health leaders required home visits of infected children, mass immunization, education efforts and even court-mandated vaccinations. The outbreak was stopped. In Dec. 2014, a measles outbreak began at Disneyland and spread in communities with low vaccination rates. Public health action stopped this large outbreak at 125 cases. To prevent further outbreaks in California, I authored Senate Bill 277, which eliminated non-medical exemptions for school vaccines. And with further U.S. measles outbreaks in 2019, I authored Senate Bill 276 to crack down on fraudulent medical exemptions. These laws — championed by California parents demanding safe schools for children — raised statewide vaccination rates and shielded our communities. As Congress waits, Health and Human Services Secretary Robert F. Kennedy Jr. is dismantling decades of public health achievement that will make America sicker. Kennedy reduced vaccine outreach, removed key public health officials, spread disinformation from his official post and suppressed data while elevating conspiracy theorists to top positions. Kennedy and the Department of Government Efficiency fired a quarter of Health and Human Services staff, gutting the Centers for Disease Control and Prevention (CDC) and National Institutes of Health teams vital to outbreak response. He installed anti-vaccine extremists as advisors, including David Grier, a discredited researcher disciplined for unethical experiments on children with autism, to 'research' if vaccines cause autism, despite decades of research debunking this myth. The CDC has been muzzled: An analysis showing high rates of measles in low vaccination areas was suppressed, and dozens of Texas vaccination clinics were forced to close. When Kennedy dismantled the CDC's communication team, his former anti-vaccine organization, Children's Health Defense, filled the void with disinformation by publishing a fake CDC-branded vaccine 'safety' website that falsely linked vaccines to autism. The site mimicked official CDC design and branding, deliberately misleading the public. After news reports exposed the deception and forced the site's removal, no federal action has been taken to investigate or prosecute this unlawful impersonation of a federal agency. Furthermore, Dr. Peter Marks, the nation's top vaccine regulator who led President Donald Trump's Operation Warp Speed, refused a demand for false data on brain swelling and death caused by the Measles-Mumps-Rubella vaccine, of which there are no credible cases. Kennedy forced him to resign. In his resignation letter, Marks wrote, 'it has become clear that truth and transparency are not desired by the secretary, but rather he wishes subservient confirmation of his misinformation and lies.' And what of the dead children from measles? Kennedy dismissed the first measles death, saying 'it's not unusual.' He blamed measles on poor nutrition, called vaccines a 'personal choice' that could cause 'adverse events' and claimed Vitamin A and cod liver oil treated measles. Subsequently, many Texas children hospitalized with measles also had Vitamin A toxicity. At his first Congressional hearing, Kennedy testified, 'I don't think people should be taking medical advice from me.' He then refused to answer whether he would vaccinate a child against polio. As Health and Human Services secretary, he cravenly refuses to save Americans in a public health crisis. How many children must get sick — and even die — before Congress demands that Kennedy and the Trump administration answer for these preventable deaths and the continued spread of a preventable disease? This flu season, as flu vaccination declined, 226 children died from influenza — the highest since the 2009-10 pandemic. Other preventable and deadly diseases, including polio and whooping cough, will also return when vaccination is hampered and discouraged. Our state has made progress in raising vaccination rates, but we are not immune to Kennedy's dangerous vaccine disinformation; California has communities with enough unvaccinated people to fuel a serious outbreak. Measles outbreaks in other states makes it imperative that California strengthen our public health defenses against sparks of infection. And California needs Congress to hold President Donald Trump and Kennedy accountable for not stopping preventable disease in America. Dr. Richard Pan is a pediatrician and former California state senator who authored landmark legislation to eliminate non-medical exemptions to school vaccination requirements in response to major measles outbreaks.
